Feature: MIV Validates Biocompatibility. Xtreme Floats More Boats.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: MIV Validates Biocompatibility. Xtreme Floats More Boats. MIV Therapeutics (OTCBB: MIVT) issued two significant press releases late last week regarding product studies that markedly advance the importance of both its technologies as well as move
Trading Alert: Stream - Like Buying Cable Stocks 20 Years Ago.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Trading Alert: Stream - Like Buying Cable Stocks 20 Years Ago. US Cable penetration is now 67 percent or 80 million households. In 1981, that penetration was 28 percent. Revenue for cable operators in 1985 was less than $10 billion compared to $57 billio
Feature: Biocurex - Blood Test Detects More Cancers. MarketNotes.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: Biocurex - Blood Test Detects More Cancers. MarketNotes. Until a cure for cancer is found, early detection of this disease remains paramount. Biocurex (BOCX.PK) announced today (release below) that it had found that its RECAF blood test detected
Trading Alert: Spescom - (Organizing) Knowledge is Power.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Trading Alert: Spescom - (Organizing) Knowledge is Power. There are lots of software companies. Then there's San Diego-based Spescom Software (OTCBB: SPCO). Critical business information isn't of much use if all types of that information aren't organized
Feature: Biophan - Accumulate For the Long-Term.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: Biophan - Accumulate For The Long-Term. On September 25th, 2004 when we last visited with nanotech firm Biophan (OTCBB: BIPH), we suggested that investors should consider accumulating the shares at around 80-ish cents. For those who bought BIPH
<<292  293  294  295  296  297  298  299  300  301  >>